Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $7.2900 (0.28%) ($7.1200 - $8.2000) on Mon. May. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 33.94% (three month average) | RSI | 89 | Latest Price | $7.2900(0.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 17.2% a day on average for past five trading days. | Weekly Trend | CAPR advances 137.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) XRT(23%) PAVE(20%) XHB(20%) XLF(20%) IWN(19%) | Factors Impacting CAPR price | CAPR will decline at least -16.97% in a week (0% probabilities). USO(-50%) TLT(-24%) BND(-22%) GLD(-17%) VXX(-14%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -16.97% (StdDev 33.94%) | Hourly BBV | 0 () | Intraday Trend | -0.8% | | | |
|
5 Day Moving Average | $6.49(12.33%) | 10 Day Moving Average | $4.45(63.82%) | 20 Day Moving Average | $3.03(140.59%) | To recent high | -14.2% | To recent low | 4.1% | Market Cap | $144m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |